ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Protenus is Top Performing Solution in Two Segments Based on 2023 Best in KLAS Report

Healthcare compliance analytics company achieves highest score for Patient Privacy Monitoring and Drug Diversion Surveillance Solutions

Protenus, the leading healthcare compliance analytics platform empowering healthcare to eliminate risk, received the highest overall performance score for both its patient privacy monitoring and drug diversion surveillance solutions in the recently published 2023 Best in KLAS: Software & Services report. Privacy violations and clinical drug diversion create huge risks for hospitals' and health systems' reputations and finances and the safety of their patients, workforces, and communities at-large. KLAS' annual report, based on survey responses from hospital customers, grades vendors on their ability to consistently deliver guidance, analytics, and insight that helps their customers identify and prevent privacy data breaches and drug diversion. 

According to KLAS CEO Adam Gale, "The 2023 Best in KLAS report highlights the top-performing healthcare IT solutions as determined by extensive evaluations and conversations with thousands of healthcare providers. These distinguished winners have demonstrated exceptional dedication to improving and innovating the industry, and their efforts are recognized through their inclusion in this report."

Hospital stakeholder input offers commentary such as, "I tell folks to save themselves all the trouble by just starting with Protenus and getting on with things. Protenus will implement their software faster, better, sooner, and with a more robust interface than anyone else will. The competition has a heck (sic) of a long way to go to catch up to Protenus. Protenus is probably the best-kept secret. I can't say enough great things about Protenus. I really can't think of anything that they could do differently that would be better. I think Protenus is on the perfect track right now." - KLAS Survey Respondent, March 2022.  

Protenus CEO and Co-Founder Nick Culbertson remarked, "Our AI-driven solutions help our customers take a preventive approach to patient privacy breaches and drug diversion, which is critical for mitigating risk. We are truly appreciative of the time our customers take to respond to KLAS inquiries, providing thoughtful feedback so we can continue to deliver high-quality support and offer leading solutions to top healthcare organizations nationwide. We are committed to our customer community and rely on their partnership and feedback as we work together to strengthen healthcare compliance and reduce risk within their organizations."

About Protenus

Protenus harnesses the power of AI to provide healthcare organizations with scalable risk-reduction solutions that drive the safest patient outcomes while protecting the reputation of the organizations. We are committed to innovation, determined to reduce risk, and focused on supporting our community of employees, customers, and ultimately, patients. Empowering healthcare to eliminate risk is at the heart of all we do. Founded in 2014, Protenus is a three-time winner of Forbes' America's Best Startup Employers, is a Great Place to Work®-Certified company, and was named one of 2021 CBInsights Digital Health 150, one of The Best Places to Work in Healthcare by Modern Healthcare, and one of the Best Places to Work in Baltimore by the Baltimore Business Journal and the Baltimore Sun. Learn more at Protenus.com and follow us on Twitter @Protenus.

About KLAS

KLAS is a research and insights firm on a global mission to improve healthcare delivery by amplifying the provider's voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data and insights on software, services and medical equipment to deliver timely reports, trends and statistical overviews. The research directly represents the provider's voice and acts as a catalyst for improving vendor performance. For more information on KLAS Research, visit www.klasresearch.com.

Contact Information:
Amanda Rogers
Strategic Marketing Manager
amanda.rogers@protenus.com


Original Source: Protenus is Top Performing Solution in Two Segments Based on 2023 Best in KLAS Report
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.